1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENXBIO INC
Regenxbio Inc XNAS: RGNX

Regenxbio Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...

Read More
9.12 0.19 (2.13%)
32.34% Fall from 52W High
403.8K
XNAS Volume

XNAS 02 Sep, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Regenxbio Inc is on 09 Sep 2025 for the purpose of Baird 2025 Global Healthcare Conference See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
22.0 / 100
Momentum Score
Technically Moderately Bullish
66.6 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 226%
12 analysts

20

S

12

W

5

O

0

T

SWOT Analysis

Regenxbio Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..